Vital Chemtech IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Chemical sector. Beeline Capital Advisors is the merchant banker of Vital Chemtech IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th July 2022.
Vital Chemtech IPO posted revenues of ₹ 129.60 crores and PAT of ₹ 16.20 crores in FY23 on annualised basis.Financial results of Vital Chemtech IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | Apr-22 | FY22 | FY21 | FY20 | |
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 89.92 | 80.94 | 30.41 | 23.18 | |
Net Worth | 14.73 | 13.37 | 5.97 | 3.04 | |
Total Debt | 34.19 | 35.00 | 10.06 | 9.54 | |
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
10.55
126.60 |
57.61 | 47.39 | 41.16 | |
EBITDA
EBITDA on annualised basis |
1.66
19.92 |
11.48 | 6.44 | 4.18 | |
PAT
PAT on annualised basis |
1.35
16.20 |
6.71 | 2.94 | 1.05 |
Vital Chemtech IPO PAT Margin is 12.80 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Vital Chemtech IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | Apr-22 | FY22 | FY21 | FY20 |
---|---|---|---|---|
EBITDA Margin (%) | 15.73 | 19.93 | 13.59 | 10.16 |
PAT Margin (%) | 12.80 | 11.65 | 6.20 | 2.55 |
EPS (₹) | 0.80 | 8.66 | 1.75 | 0.63 |
ROE (%) | 9.16 | 50.19 | 49.25 | 34.54 |
ROCE (%) | [●] | [●] | [●] | [●] |
ROA (%) | 1.50 | 8.29 | 9.67 | 4.53 |
Debt to Equity | 2.32 | 2.62 | 1.69 | 3.14 |
The market Capitalisation of Vital Chemtech IPO is ₹ 241.91 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Vital Chemtech IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Vital Chemtech IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Vital Chemtech IPO is ₹ 241.91 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Vital Chemtech IPO has a Price-to-Earnings (PE) ratio of 14.94 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Vital Chemtech IPO reported revenue of ₹ 129.60 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Vital Chemtech IPO provide insights into sales growth, market demand, and business scalability.
Vital Chemtech recorded an EBITDA of ₹ 19.92 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Vital Chemtech Profit After Tax (PAT) is ₹ 16.20 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Vital Chemtech operates in Chemical and Manufacturing Of Phosphorus Derivatives Products. The Issue is listed on NSE EMERGE in Nov, 2022. Vital Chemtech IPO size was 64.64 with Issue price of 101.00 .
Merchant Banker(s) of Vital Chemtech IPO: Beeline Capital Advisors Private Limited
Vital Chemtech IPO subscription was 79.33 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Vital Chemtech IPO listed at a listing price of 163.10 against the offer price of 101.00.
The current market price of Vital Chemtech is 65.00.
Why Us?